Endologix LLC
(Other OTC/NBB : ELGX)

( )
ELGX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -3.11%523.771.0%$689.89m
DHRDanaher Corp. -3.54%268.220.7%$672.27m
ABTAbbott Laboratories -0.64%101.790.8%$569.47m
MDTMedtronic Plc -2.35%82.440.6%$539.60m
ISRGIntuitive Surgical, Inc. -4.56%188.680.8%$345.55m
SYKStryker Corp. -1.35%208.561.3%$304.64m
BSXBoston Scientific Corp. -2.18%39.771.0%$259.19m
BDXBecton, Dickinson & Co. -2.51%222.661.0%$257.90m
DXCMDexCom, Inc. 7.28%102.141.9%$246.46m
EWEdwards Lifesciences Corp. -2.59%84.240.4%$236.92m
ALGNAlign Technology, Inc. -4.85%211.586.4%$200.89m
AAgilent Technologies, Inc. -3.59%127.441.7%$189.61m
BAXBaxter International, Inc. -1.10%55.631.8%$168.05m
STESTERIS Plc (Ireland) -1.47%170.213.1%$146.01m
MTDMettler-Toledo International, Inc. -3.69%1158.775.9%$134.58m

Company Profile

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologix's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.